01 / 20

Protein Function
Binding Sites, Allostery & Specificity

Explore how proteins recognize their partners through binding sites, change shape via allosteric regulation, and achieve remarkable molecular specificity.

Biochemistry

What Is a Binding Site?

A binding site is a specific region on a protein's surface where another molecule, called a ligand, attaches through non-covalent interactions. The shape, charge, and hydrophobicity of the binding site determine which ligand can bind and how tightly it holds on.

Protein Binding Site Ligand Non-covalent: H-bonds, ionic, van der Waals, hydrophobic

Ligand Specificity

Proteins do not bind every molecule they encounter. Specificity arises from the precise complementarity between the binding site and its ligand in three dimensions: matching shape, charge, and hydrophobicity.

Shape
The 3D contour of the pocket matches the ligand geometry, excluding molecules of the wrong size or form.
Charge
Positive residues attract negative ligand groups and vice versa: opposite charges create ionic bonds and H-bonds.
Hydrophobicity
Non-polar patches in the pocket attract non-polar ligand regions, while polar areas repel them.

Lock-and-Key vs. Induced Fit

Lock-and-Key Rigid protein Ligand Exact pre-formed fit Induced Fit Open L Protein reshapes on binding Conformational change upon contact

Measuring Affinity: \( K_d \)

The dissociation constant \( K_d \) quantifies how tightly a protein binds its ligand. It describes the equilibrium between bound and free states:

Low \( K_d \)
High affinity: the protein holds tightly to its ligand. Less ligand is needed to saturate binding.
High \( K_d \)
Low affinity: the protein releases the ligand easily. More ligand is required for binding.

What Is Allostery?

Allosteric regulation occurs when a molecule binds at a site other than the active site (the allosteric site) and causes a conformational change that alters the protein's activity at the active site.

No Effector Bound Active Site Allosteric Site Effector binds Effector Bound Active Site Changed! E Effector Binding at one site changes shape at a distant site "allo" = other, "steric" = shape

Activators vs. Inhibitors

Allosteric effectors come in two flavors. An activator stabilizes the active conformation (R state), while an inhibitor stabilizes the inactive conformation (T state).

Allosteric Activator
Shifts equilibrium toward the R (relaxed) state: the active site opens wider, increasing substrate affinity and catalytic rate.
Allosteric Inhibitor
Shifts equilibrium toward the T (tense) state: the active site narrows or distorts, reducing substrate binding and slowing activity.

Cooperativity: The Hemoglobin Story

Cooperative binding is a special case of allostery in multi-subunit proteins. When the first ligand binds, it increases the affinity of neighboring subunits for additional ligand molecules.

Fractional Saturation (\(Y\))
\(\text{Ligand}\)
 0 1.0 Myoglobin (Hyperbolic) Hemoglobin (Sigmoidal)
\( P_{50} \)

Competitive vs. Allosteric Inhibition

Feature Competitive Allosteric
Binding location Active site Allosteric (different) site
Resembles substrate? Yes No
Overcome by excess substrate? Yes No
Effect on \( V_{\max} \) Unchanged Decreased
Effect on \( K_m \) (apparent) Increased Unchanged or variable
Mechanism Blocks substrate entry Conformational change

How to Analyze Binding and Regulation

1
Identify the binding site. Is the molecule binding at the active site or at a separate allosteric site?
2
Determine the effect. Does binding increase activity (activation) or decrease it (inhibition)?
3
Check for competition. Can excess substrate overcome the effect? If yes, it is competitive. If no, it is allosteric or non-competitive.
4
Look at the binding curve. Hyperbolic suggests simple binding (one site). Sigmoidal suggests cooperativity in a multi-subunit protein.
5
Evaluate \( K_d \) or \( K_m \) changes. Shifts in these constants reveal whether binding affinity or catalytic efficiency has changed.

Example 1: Hemoglobin Oxygen Binding

Scenario: Hemoglobin is a tetramer (four subunits). When the first \(\text{O}_2\) molecule binds to one subunit, the other three subunits shift from the T state to the R state. What type of regulation is this?

1
Binding site: \(\text{O}_2\) binds at the heme group in the active site of each subunit.
2
Effect on other subunits: Binding at one subunit changes the conformation of neighboring subunits (different physical locations).
3
Classification: This is positive cooperativity: a form of homotropic allosteric regulation, where the substrate itself acts as the allosteric effector.

Example 2: Feedback Inhibition

Scenario: In the biosynthesis of isoleucine, the final product (isoleucine) binds to the first enzyme in the pathway (threonine deaminase) at a site separate from the active site, shutting it down.

Threonine Enzyme 1 Thr deaminase ... Isoleucine Feedback Inhibition (allosteric)

Example 3: Drug Design and Specificity

Scenario: Scientists design a drug that mimics the substrate's shape and binds in the enzyme's active site, blocking the natural substrate. The inhibition can be overcome by adding more substrate.

1
Binding site: The drug binds at the active site (same location as the substrate).
2
Structural similarity: The drug resembles the substrate in shape and charge, exploiting the binding site's specificity.
3
Reversibility: Excess substrate can outcompete the drug, confirming competitive inhibition.

Common Mistakes

✕ Confusing Binding Site Types
Saying an allosteric inhibitor binds at the active site. By definition, allosteric means a different site from where the substrate binds.
✕ Thinking Allostery is Always Inhibition
Allosteric effectors can be activators (stabilizing R state) or inhibitors (stabilizing T state). Don't assume one direction.
✕ Mixing Up \( K_d \) Direction
A lower \( K_d \) means tighter binding, not weaker. Students often reverse this: low number = high affinity.

Summary: Binding, Allostery & Specificity

Concept Definition Key Feature
Binding Site Region where ligand attaches Shape + charge complementarity
Specificity Selectivity for one ligand Lock-and-key / induced fit
\( K_d \) Dissociation constant Low = tight; high = weak
Allostery Remote-site regulation Conformational change
Cooperativity Subunit-to-subunit signaling Sigmoidal binding curve
Feedback Inhibition End product inhibits first enzyme Allosteric, heterotropic

Question 1 of 5

A molecule binds to an enzyme at a site other than the active site and decreases the enzyme's catalytic rate. Adding more substrate does not restore activity. What type of inhibition is this?

Question 2 of 5

Hemoglobin displays a sigmoidal oxygen-binding curve. This shape indicates:

Question 3 of 5

An enzyme has a \( K_d \) of \( 10^{-9}\,\text{M} \) for Ligand A and a \( K_d \) of \( 10^{-3}\,\text{M} \) for Ligand B. Which statement is correct?

Question 4 of 5

In the isoleucine biosynthesis pathway, the final product (isoleucine) inhibits the first enzyme (threonine deaminase) by binding its allosteric site. This is an example of:

Question 5 of 5

A researcher adds a drug that binds the active site of an enzyme and closely resembles the substrate. At high substrate concentrations, enzyme activity returns to near-normal levels. This drug is best classified as: